Jehan Tamboowalla

Jehan Tamboowalla, is currently VP, Head of New Products, Ophthalmology at Novartis. Jehan brings more than 20 years of Product Launch, Commercial, and R&D experience spanning Ophthalmology, Immunology and Cell & Gene Therapies. While at Novartis, Jehan has been the worldwide commercial lead on numerous evaluations and transactions including Lubris BioPharma (2017), Encore Vision (2017), Spark Therapeutics (2018), and Shire/Takeda (2019). Prior to joining Novartis, Jehan was Managing Director at Red Team Associates, a boutique consulting firm, specialized in working with emerging biopharma, private equity, and venture capital clients. Prior to Red Team, Jehan’s industry experience includes multiple product launches and marketing roles of increasing responsibility at Bayer AG, Bausch & Lomb, and GSK. Jehan continues to mentor and advise leaders at emerging BioPharma and Biotech companies. Jehan holds BS and MS degrees in Biotechnology and Biology from the Worcester Polytechnic Institute, and an International MBA from Thunderbird.